Table 3.
Enrolment | Allocation | Intervention | Close-out | |||
---|---|---|---|---|---|---|
Timepoint | 0 | 0 | 30th | 60th | 90th | 120th |
Enrolment | ||||||
Eligibility screen | X | |||||
Written informed consent | X | |||||
Collect demographics and baseline clinical data | X | |||||
Collect a biological sample | O | O | ||||
Allocation | X | |||||
Interventions | ||||||
Intervention group | ||||||
Control group | ||||||
Assessments | ||||||
LPSI | X | X | X | X | ||
Reported adverse events | X | X | X | |||
Demographics and baseline clinical data | X | |||||
Microbial profile | O |
O, 50% of the participants were randomly chosen to collect saliva, feces, and skin samples.